What is Catalyst Clinical Research?
Catalyst Clinical Research operates as a premier contract research organization, delivering bespoke solutions tailored to the complex requirements of the biotech and biopharmaceutical industries. The firm distinguishes itself through two primary pillars: Catalyst Oncology, which provides comprehensive, full-service support for cancer drug development, and Catalyst Flex, a functional service provider model designed for multi-therapeutic agility. By leveraging an extensive site network and deep clinical expertise, the organization facilitates critical advancements in drug development, data management, and clinical operations. Their market position is defined by a focus on high-touch, flexible partnerships that allow biotech sponsors to navigate the regulatory and logistical hurdles of modern clinical trials with greater efficiency and precision.
How much funding has Catalyst Clinical Research raised?
Catalyst Clinical Research has raised a total of $119M across 1 funding round:
Debt
$119M
Debt (2022): $119M with participation from MidCap Financial
Key Investors in Catalyst Clinical Research
MidCap Financial
MidCap Financial is a middle-market-focused finance firm that provides flexible, asset-based lending solutions to support the growth and operational needs of companies across various sectors, including healthcare and life sciences.
What's next for Catalyst Clinical Research?
With this major strategic investment, Catalyst Clinical Research is well-positioned to accelerate its growth trajectory and expand its footprint in the oncology and multi-therapeutic research markets. The capital will likely be deployed to enhance the firm's technological infrastructure, broaden its site network, and recruit top-tier clinical talent to meet the increasing demand for specialized CRO services. As the biopharmaceutical industry continues to prioritize outsourcing for complex trial management, Catalyst is poised to leverage its flexible service model to capture additional market share. Future strategic initiatives will likely focus on integrating advanced data analytics into their clinical workflows, further cementing their reputation as a vital partner for companies navigating the transition from early-stage research to late-stage clinical validation.
See full Catalyst Clinical Research company page
